151
A
Abnormally shaped waveforms, 9
Abnormally wide or narrow pulse
pressure, 9–10
ABO incompatibility, 24
Absence of breathing, 73
Acidosis, 24
Air leaks
mechanical ventilation and, 79
surfactant therapy and, 101
Albuterol, 134
Aldactone, 135
Alkalosis, 24
Aminophylline, 134
Anemia
monitoring for, 119–120
severe, 30–34, 33, 35
Anticonvulsant drugs, 139
Apnea
mechanical ventilation and, 73,
76
monitoring for, 117–119
Arterial blood gases
chronic lung disease and, 137
mechanical ventilation and, 78
surfactant therapy and, 99
Arterial catheters, 4
Aspiration syndrome, 96
Assessment
of family, 123–124, 140
of growth, 114–117, 140
Assisted ventilation. See Mechanical
ventilation
B
Blocked or displaced endotracheal
tubes and mechanical
ventilation, 79
Blood
amount used for exchange trans-
fusion, 24
preparation for exchange transfu-
sion, 24–25
preservation, 24
types of donor, 23–24
urea nitrogen, 139
Blood pressure, 2
calibration of the monitor, 15–16
equipment needed, 4–5
method of measurement, 4
monitoring types, 4
normal ranges, 6–7
posttest, 12
pretest, 3
self-tests, 5, 10–11
transducer monitoring, 5, 10–11,
13–17
waveforms interpretation, 8–10
Body weight, 116
Bradycardia, 118
BUN. See Blood, urea nitrogen
C
Caffeine, 135
Calibration, blood pressure monitor,
15–16
Cardiac complications of exchange
transfusions, 28
Catheters, arterial, 4, 9
Catheters, peripheral arterial (PAC),
23, 32
Catheters, umbilical arterial (UAC),
23, 27, 32
Catheters, umbilical venous (UVC),
23, 26–27, 32
CHD. See Congenital heart disease
(CHD)
Chest movement and mechanical
ventilation, 77
Chest x-rays, 135, 141
Chlorothiazide, 135
Cholestatic jaundice, 131
Chronic lung disease (CLD), 130,
134–137
Citrate phosphate dextrose adenine
(CPDA-1), 24
CLD. See Chronic lung disease
(CLD)
Clots
within catheters, 9
complications of exchange trans-
fusions, 28
exchange transfusion and, 26
Commercial stabilizers, 84–88
Complications, potential
direct transfusion, 36
exchange transfusions, 27–29, 32
mechanical ventilation, 78–79
surfactant therapy, 100–101
Congenital heart disease (CHD),
131–132, 141–142
Continuing care, 108, 111
administering immunizations
during, 120–121
assessment of family during,
123–124, 140
assessment of growth during,
114–117, 140
cholestatic jaundice and, 131
chronic lung disease and, 130,
134–137
congenital heart disease and,
131–132, 141–142
developmental care and, 124
discharge and, 127–129
gastroesophageal reflux and, 130
hearing deficits and, 121
hydrocephalus and, 131, 140
late head ultrasound during, 122
monitoring and treatment
guidelines for babies with
special problems, 134–142
monitoring for anemia during,
119–120
monitoring for apnea during,
117–119
patent ductus arteriosus and,
131–132
posttest, 147
pretest, 109–110
recommended routines, 143
retinopathy of prematurity and,
121–122, 138
seizures and, 131, 139
self-tests, 125–126, 129, 133,
144–146
short-bowel syndrome and, 131,
139
sleep position/environment and,
123
special problems that may be
encountered in babies
requiring, 130–132,
134–142
specific issues involved in, 111–124
temperature control during,
111–112
which babies require, 111
Continuous method of exchange
transfusion, 26, 32, 49–50
Continuous positive airway pressure
(CPAP), 56, 58, 72
adjusting, 67–68
conditions that benefit from, 58
delivery, 59–60, 63–68
given by high-flow nasal cannula,
61
maintaining, 68
mechanism, 58
Index
Previous Page Next Page